Effects of bioactive peptides combined with probiotics on serum uric acid in patients with hyperuricemia

Objective: To evaluate the effect of bioactive peptides combined with probiotics on serum uric acid (SUA) in patients with hyperuricemia (HUA), so as to provide the evidence for prevention and treatment of HUA. Methods: The patients with HUA aged 18 to 65 years were selected and randomly divided int...

Full description

Saved in:
Bibliographic Details
Main Author: HAN Dan,ZHAO Ya,HUANG Enshan,YE Shuhua,WANG Wanjin,WU Fangmin,WANG Dingliang,ZHANG Ronghua
Format: Article
Language:zho
Published: Editorial Office of China Preventive Medicine Journal 2025-01-01
Series:预防医学
Subjects:
Online Access:http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2025.01.009
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825206734711422976
author HAN Dan,ZHAO Ya,HUANG Enshan,YE Shuhua,WANG Wanjin,WU Fangmin,WANG Dingliang,ZHANG Ronghua
author_facet HAN Dan,ZHAO Ya,HUANG Enshan,YE Shuhua,WANG Wanjin,WU Fangmin,WANG Dingliang,ZHANG Ronghua
author_sort HAN Dan,ZHAO Ya,HUANG Enshan,YE Shuhua,WANG Wanjin,WU Fangmin,WANG Dingliang,ZHANG Ronghua
collection DOAJ
description Objective: To evaluate the effect of bioactive peptides combined with probiotics on serum uric acid (SUA) in patients with hyperuricemia (HUA), so as to provide the evidence for prevention and treatment of HUA. Methods: The patients with HUA aged 18 to 65 years were selected and randomly divided into an intervention group and a control group. The patients in the intervention group received bioactive peptides combined with probiotics for 28 days at a dose of 3 g/d, while the patients in the control group received an equal dose of placebos. Demographic information, body mass index (BMI), blood pressure and blood lipid were collected through questionnaire surveys, physical examination and laboratory tests. SUA levels were detected before and after 14 days and 28 days of interventions. The differences of SUA levels between the two groups were compared using generalized estimation equation. Results: Totally 108 patients with HUA were recruited, including 54 patients in the intervention group and 53 patients in the control group (1 dropout). Before interventions, there were no statistically significant differences in gender, age, course of HUA, exercise duration, frequency of alcohol consumption, frequency of meat broth consumption, BMI, prevalence of hypertension and prevalence of dyslipidemia between the two groups (all P>0.05). After 14 days of interventions, the SUA levels of the patients in the intervention group decreased by 3.00 μmol/L, while those in the control group increased by 7.00 μmol/L. After 28 days of interventions, the SUA levels of the patients in the intervention group and the control group decreased by 26.00 μmol/L and 16.00 μmol/L, respectively. However, there was no statistically significant interaction between the intervention time and group (both P>0.05). Subgroup analysis showed that after 28 days of interventions, the decrease in SUA levels in the patients aged 55 years and older and without hypertension in the intervention group was greater than those in the control group (both P<0.05). Conclusions: Bioactive peptides combined with probiotics showed no significant difference in reducing SUA levels in patients with HUA compared to the control group. The effect was more significant for patients aged 55 years and older and without hypertension.
format Article
id doaj-art-9f5fa7b804934fb7b254532c1f8eaa48
institution Kabale University
issn 2096-5087
language zho
publishDate 2025-01-01
publisher Editorial Office of China Preventive Medicine Journal
record_format Article
series 预防医学
spelling doaj-art-9f5fa7b804934fb7b254532c1f8eaa482025-02-07T06:50:21ZzhoEditorial Office of China Preventive Medicine Journal预防医学2096-50872025-01-01371404510.19485/j.cnki.issn2096-5087.2025.01.009Effects of bioactive peptides combined with probiotics on serum uric acid in patients with hyperuricemiaHAN Dan,ZHAO Ya,HUANG Enshan,YE Shuhua,WANG Wanjin,WU Fangmin,WANG Dingliang,ZHANG RonghuaObjective: To evaluate the effect of bioactive peptides combined with probiotics on serum uric acid (SUA) in patients with hyperuricemia (HUA), so as to provide the evidence for prevention and treatment of HUA. Methods: The patients with HUA aged 18 to 65 years were selected and randomly divided into an intervention group and a control group. The patients in the intervention group received bioactive peptides combined with probiotics for 28 days at a dose of 3 g/d, while the patients in the control group received an equal dose of placebos. Demographic information, body mass index (BMI), blood pressure and blood lipid were collected through questionnaire surveys, physical examination and laboratory tests. SUA levels were detected before and after 14 days and 28 days of interventions. The differences of SUA levels between the two groups were compared using generalized estimation equation. Results: Totally 108 patients with HUA were recruited, including 54 patients in the intervention group and 53 patients in the control group (1 dropout). Before interventions, there were no statistically significant differences in gender, age, course of HUA, exercise duration, frequency of alcohol consumption, frequency of meat broth consumption, BMI, prevalence of hypertension and prevalence of dyslipidemia between the two groups (all P>0.05). After 14 days of interventions, the SUA levels of the patients in the intervention group decreased by 3.00 μmol/L, while those in the control group increased by 7.00 μmol/L. After 28 days of interventions, the SUA levels of the patients in the intervention group and the control group decreased by 26.00 μmol/L and 16.00 μmol/L, respectively. However, there was no statistically significant interaction between the intervention time and group (both P>0.05). Subgroup analysis showed that after 28 days of interventions, the decrease in SUA levels in the patients aged 55 years and older and without hypertension in the intervention group was greater than those in the control group (both P<0.05). Conclusions: Bioactive peptides combined with probiotics showed no significant difference in reducing SUA levels in patients with HUA compared to the control group. The effect was more significant for patients aged 55 years and older and without hypertension.http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2025.01.009bioactive peptidesprobioticshyperuricemiaserum uric acid
spellingShingle HAN Dan,ZHAO Ya,HUANG Enshan,YE Shuhua,WANG Wanjin,WU Fangmin,WANG Dingliang,ZHANG Ronghua
Effects of bioactive peptides combined with probiotics on serum uric acid in patients with hyperuricemia
预防医学
bioactive peptides
probiotics
hyperuricemia
serum uric acid
title Effects of bioactive peptides combined with probiotics on serum uric acid in patients with hyperuricemia
title_full Effects of bioactive peptides combined with probiotics on serum uric acid in patients with hyperuricemia
title_fullStr Effects of bioactive peptides combined with probiotics on serum uric acid in patients with hyperuricemia
title_full_unstemmed Effects of bioactive peptides combined with probiotics on serum uric acid in patients with hyperuricemia
title_short Effects of bioactive peptides combined with probiotics on serum uric acid in patients with hyperuricemia
title_sort effects of bioactive peptides combined with probiotics on serum uric acid in patients with hyperuricemia
topic bioactive peptides
probiotics
hyperuricemia
serum uric acid
url http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2025.01.009
work_keys_str_mv AT handanzhaoyahuangenshanyeshuhuawangwanjinwufangminwangdingliangzhangronghua effectsofbioactivepeptidescombinedwithprobioticsonserumuricacidinpatientswithhyperuricemia